About Halda Therapeutics
Halda Therapeutics is a company based in New Haven (United States) founded in 2019 by Craig Crews was acquired by Johnson & Johnson in November 2025.. Halda Therapeutics has raised $216.67 million across 4 funding rounds from investors including Johnson & Johnson, RA Capital and Canaan. Halda Therapeutics offers products and services including RIPTAC Therapeutics. Halda Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter New Haven, United States
- Founders Craig Crews
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Halda Therapeutics Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$216.67 M (USD)
in 4 rounds
-
Latest Funding Round
$126.47 M (USD), Series B
Aug 12, 2024
-
Investors
Johnson & Johnson
& 12 more
-
Employee Count
Employee Count
-
Acquired by
Johnson & Johnson
(Nov 17, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Halda Therapeutics
Halda Therapeutics offers a comprehensive portfolio of products and services, including RIPTAC Therapeutics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drugs that hold proteins to selectively kill cancer cells
Unlock access to complete
Funding Insights of Halda Therapeutics
Halda Therapeutics has successfully raised a total of $216.67M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $126.47 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $126.5M
-
First Round
First Round
(28 Feb 2019)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series B - Halda Therapeutics | Valuation | Deep Track Capital , Frazier Life Sciences | |
| May, 2024 | Amount | Series B - Halda Therapeutics | Valuation |
investors |
|
| Dec, 2021 | Amount | Series B - Halda Therapeutics | Valuation | Access Biotechnology |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Halda Therapeutics
Halda Therapeutics has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Johnson & Johnson, RA Capital and Canaan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep Track Capital is engaged in biotechnology investment activities.
|
Founded Year | Domain | Location | |
|
Healthcare investment firm focused on novel therapeutics development.
|
Founded Year | Domain | Location | |
|
Biomedical innovations are transformed into therapies by Vida Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Halda Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Halda Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Halda Therapeutics Comparisons
Competitors of Halda Therapeutics
Halda Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Halda Therapeutics
Frequently Asked Questions about Halda Therapeutics
When was Halda Therapeutics founded?
Halda Therapeutics was founded in 2019.
Where is Halda Therapeutics located?
Halda Therapeutics is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Who is the current CEO of Halda Therapeutics?
Craig Crews is the current CEO of Halda Therapeutics. They have also founded this company.
Is Halda Therapeutics a funded company?
Halda Therapeutics is a funded company, having raised a total of $216.67M across 4 funding rounds to date. The company's 1st funding round was a Series B of $40.99M, raised on Feb 28, 2019.
What does Halda Therapeutics do?
Developer of precision therapeutics for cancer treatment. It offers a lead drug candidate which is a RIPTAC therapeutic that utilizes androgen receptor as a targeting protein to selectively deliver the drug for the treatment of metastatic, castrate-resistant prostate cancer, and tumors.
Who are the top competitors of Halda Therapeutics?
Halda Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Halda Therapeutics offer?
Halda Therapeutics offers RIPTAC Therapeutics.
Who are Halda Therapeutics's investors?
Halda Therapeutics has 13 investors. Key investors include Johnson & Johnson, RA Capital, Canaan, Elm Street Ventures, and Deep Track Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.